Suzhou MedicalSystem Technology Co., Ltd. (603990.SS)
CNY 14.1
(3.22%)
CNY 14.1
(3.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -179.96 Million CNY | -271.94% |
| 2022 | 67.06 Million CNY | -7.95% |
| 2021 | 76.56 Million CNY | 2.73% |
| 2020 | 69.8 Million CNY | 1.67% |
| 2019 | 82.38 Million CNY | 1.86% |
| 2018 | 76.22 Million CNY | 13.27% |
| 2017 | 69.24 Million CNY | 26.14% |
| 2016 | 32.06 Million CNY | 11.12% |
| 2015 | 47.29 Million CNY | 9.28% |
| 2014 | 48.54 Million CNY | 20.57% |
| 2013 | 39.17 Million CNY | 457.96% |
| 2012 | 10.26 Million CNY | 2289.71% |
| 2011 | -340.85 Thousand CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -69.4 Million CNY | -69.4% |
| 2024 Q2 | -45.63 Million CNY | -231.43% |
| 2024 Q1 | 27.79 Million CNY | 120.71% |
| 2023 Q3 | -9.07 Million CNY | 71.47% |
| 2023 FY | - CNY | -271.94% |
| 2023 Q4 | -133.86 Million CNY | -1375.75% |
| 2023 Q1 | -5.66 Million CNY | -117.35% |
| 2023 Q2 | -31.79 Million CNY | -461.62% |
| 2022 FY | - CNY | -7.95% |
| 2022 Q3 | 297.59 Thousand CNY | -98.6% |
| 2022 Q2 | 21.32 Million CNY | 50.21% |
| 2022 Q1 | 14.2 Million CNY | -68.45% |
| 2022 Q4 | 32.63 Million CNY | 10867.31% |
| 2021 Q2 | 19.85 Million CNY | 143.37% |
| 2021 FY | - CNY | 2.73% |
| 2021 Q4 | 45 Million CNY | 1163.99% |
| 2021 Q3 | 3.56 Million CNY | -82.07% |
| 2021 Q1 | 8.15 Million CNY | -84.42% |
| 2020 Q3 | 20.69 Million CNY | 15.05% |
| 2020 Q4 | 52.34 Million CNY | 152.98% |
| 2020 FY | - CNY | 1.67% |
| 2020 Q1 | -15.44 Million CNY | -129.59% |
| 2020 Q2 | 17.98 Million CNY | 216.48% |
| 2019 Q3 | 8.62 Million CNY | -48.89% |
| 2019 Q1 | -2.88 Million CNY | -105.11% |
| 2019 FY | - CNY | 1.86% |
| 2019 Q4 | 52.17 Million CNY | 505.23% |
| 2019 Q2 | 16.86 Million CNY | 684.12% |
| 2018 Q3 | 5.56 Million CNY | -65.41% |
| 2018 Q2 | 16.09 Million CNY | 538.34% |
| 2018 Q1 | -3.67 Million CNY | -112.66% |
| 2018 FY | - CNY | 13.27% |
| 2018 Q4 | 56.53 Million CNY | 915.43% |
| 2017 Q1 | -9.54 Million CNY | 89.86% |
| 2017 FY | - CNY | 26.14% |
| 2017 Q4 | 29 Million CNY | 66.78% |
| 2017 Q3 | 17.39 Million CNY | -38.9% |
| 2017 Q2 | 28.46 Million CNY | 398.21% |
| 2016 FY | - CNY | 11.12% |
| 2016 Q2 | 22.04 Million CNY | 408.27% |
| 2016 Q1 | -7.15 Million CNY | 89.05% |
| 2016 Q4 | -94.16 Million CNY | -1493.25% |
| 2016 Q3 | 6.75 Million CNY | -69.34% |
| 2015 FY | - CNY | 9.28% |
| 2015 Q4 | -65.29 Million CNY | 0.0% |
| 2014 Q1 | 5.69 Million CNY | 0.0% |
| 2014 FY | - CNY | 20.57% |
| 2014 Q2 | 5.69 Million CNY | 0.0% |
| 2013 FY | - CNY | 457.96% |
| 2012 FY | - CNY | 2289.71% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|